Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00667134 · ClinicalTrials.gov registry record
Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic Sclerosis
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 26
- Enrollment target
NCT00667134 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 26 participants.
The verdict
NCT00667134 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
This study is to determine if subjects with .systemic sclerosis have stimulatory autoantibodies to the PDGF receptor and to confirm activation (phosphorylation) of the PDGF receptor in skin sites with varying degrees of skin thickening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2008-03 |
| Est. Completion | 2012-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00667134
The ClinicalTrials.gov registry entry for NCT00667134 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00667134 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00667134 about?
NCT00667134 is a clinical study titled "Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic Sclerosis". This study is to determine if subjects with .systemic sclerosis have stimulatory autoantibodies to the PDGF receptor and to confirm activation (phosphorylation) of the PDGF receptor in skin sites with varying degrees of skin thickening
What is the current status of trial NCT00667134?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2008-03. Estimated completion is 2012-02.
Who is sponsoring clinical trial NCT00667134?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.